These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32813900)

  • 1. What Will it Take to Move the Needle for Headache Disorders? An Advocacy Perspective.
    Shapiro RE
    Headache; 2020 Oct; 60(9):2059-2077. PubMed ID: 32813900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancouver Declaration II on Global Headache Patient Advocacy 2019.
    Dodick DW; Ashina M; Sakai F; Grisold W; Miyake H; Henscheid-Lorenz D; Craven A; Ruiz de la Torre E; Koh R; Reznik N; Bance L; Leroux E; Edvinsson L;
    Cephalalgia; 2020 Sep; 40(10):1017-1025. PubMed ID: 32345038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stigma and Migraine: Developing Effective Interventions.
    Parikh SK; Kempner J; Young WB
    Curr Pain Headache Rep; 2021 Dec; 25(11):75. PubMed ID: 34873646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advocacy in Headache Medicine: Tips at the Bedside, the Institutional Level, and Beyond.
    Arca KN; Starling AJ
    Curr Neurol Neurosci Rep; 2020 Sep; 20(11):52. PubMed ID: 32940800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equity of African American Men in Headache in the United States: A Perspective From African American Headache Medicine Specialists (Part 1).
    Charleston L; Spears RC; Flippen C
    Headache; 2020 Nov; 60(10):2473-2485. PubMed ID: 33140448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advocacy Connection Team-Now educational program for headache fellows and patients/caregivers: Assessment of educational objectives.
    Seebadri-White C; Yuan H; Young WB; Arca KN
    Headache; 2024 Apr; 64(4):374-379. PubMed ID: 38523478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advocacy for Migraine Relief: Strategic Planning to Eliminate the Burden.
    Monteith TS
    Curr Pain Headache Rep; 2022 Aug; 26(8):567-574. PubMed ID: 35716274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Discrimination perceived by people with a diagnosis of schizophrenic disorders. INternational study of DIscrimination and stiGma Outcomes (INDIGO): French results].
    Daumerie N; Vasseur Bacle S; Giordana JY; Bourdais Mannone C; Caria A; Roelandt JL
    Encephale; 2012 Jun; 38(3):224-31. PubMed ID: 22726410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to understand and address the cultural aspects and consequences of diagnosis of epilepsy, including stigma.
    Braga P; Hosny H; Kakooza-Mwesige A; Rider F; Tripathi M; Guekht A
    Epileptic Disord; 2020 Oct; 22(5):531-547. PubMed ID: 33079064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health equity, care access and quality in headache - part 1.
    Tana C; Raffaelli B; Souza MNP; de la Torre ER; Massi DG; Kisani N; García-Azorín D; Waliszewska-Prosół M
    J Headache Pain; 2024 Jan; 25(1):12. PubMed ID: 38281917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raising awareness of disabled lives and health care rationing during the COVID-19 pandemic.
    Lund EM; Ayers KB
    Psychol Trauma; 2020 Aug; 12(S1):S210-S211. PubMed ID: 32463287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine: Stigma in Society.
    Parikh SK; Young WB
    Curr Pain Headache Rep; 2019 Feb; 23(1):8. PubMed ID: 30739216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancouver Declaration on Global Headache Patient Advocacy 2018.
    Dodick D; Edvinsson L; Makino T; Grisold W; Sakai F; Jensen R; Balch A; Ruiz de la Torre E; Henscheid-Lorenz D; Craven A; Ashina M
    Cephalalgia; 2018 Nov; 38(13):1899-1909. PubMed ID: 29882695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF).
    Leonardi M; Steiner TJ; Scher AT; Lipton RB
    J Headache Pain; 2005 Dec; 6(6):429-40. PubMed ID: 16388337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies.
    Burch R; Rizzoli P; Loder E
    Headache; 2018 Apr; 58(4):496-505. PubMed ID: 29527677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of migraine in the clinical spectrum of mitochondrial disorders.
    Terrin A; Bello L; Valentino ML; Caporali L; Sorarù G; Carelli V; Maggioni F; Zeviani M; Pegoraro E
    Sci Rep; 2022 Mar; 12(1):4222. PubMed ID: 35273322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advocacy for patients with headache disorders.
    Gouider R; Lorenz DH; Craven A; Grisold W; Dodick DW
    eNeurologicalSci; 2023 Jun; 31():100466. PubMed ID: 37250108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies.
    Smitherman TA; Burch R; Sheikh H; Loder E
    Headache; 2013 Mar; 53(3):427-36. PubMed ID: 23470015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States Patients' Perspective of Living With Migraine: Country-Specific Results From the Global "My Migraine Voice" Survey.
    Gibbs SN; Shah S; Deshpande CG; Bensink ME; Broder MS; Dumas PK; Buse DC; Vo P; Schwedt TJ
    Headache; 2020 Jul; 60(7):1351-1364. PubMed ID: 32369201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increasing role of electronic media in headache.
    Do TP; Andreou AP; de Oliveira AB; Shapiro RE; Lampl C; Amin FM
    BMC Neurol; 2023 May; 23(1):194. PubMed ID: 37198539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.